Skip to content

Chair
Ranking Member
Hearings
Committee Actions
- Legislation
- Nominations
About

Published: 09.27.24

Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 1

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 2

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 3

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 4

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 5

View Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy? Photo 6

Hearings
Chairman
Ranking Member
Legislation
Nominations
About
Privacy Policy

Senate Committee on Health, Education, Labor and Pensions
428 Senate Dirksen Office Building,Washington, DC, 20510 (202) 224-5375

Chair's Newsroom

Amazon Investigation

Patients, Share Your Story

Ranking Member's Newsroom

Committee Actions

website-search

Site Search